Stella Pharma: Announcements of subscription rights for the 4th time (with exercising price revision clause) regarding the mass exercise.
Stella Pharma: Internal Control Report - 17th Period (2023/04/01 - 2024/03/31)
Stella Pharma: Securities Report - 17th Period (April 1, 2023 - March 31, 2024).
Stella Pharma: Confirmatory letter.
Stella Pharma: Bylaws 25th June 2024
Stella Pharma: Regarding matters related to dominant shareholders.
Stella Pharma: Report on corporate governance, June 25, 2024.
Stella Pharma: Matters related to business plans and growth potential.
Stella Pharma: Change report (exemption share certificates, etc.)
Stella Pharma: Announcements of individual stocks: Notification of submission of a clinical trial plan for domestic Phase I/II clinical trial of BNCT targeting malignant tumors of the chest.
Stella Pharma: Announcements of subscription rights for the 4th time (with exercising price revision clause) regarding the mass exercise.
Stella Pharma: Change report (exemption share certificates, etc.)
Stella Pharma: Announcements of individual stocks regarding the receipt of collateral in the People's Republic of China, Hainan Island operation.
Stella Pharma: Notice regarding the monthly exercise status of the 4th Stock Acquisition Rights (with exercise price amendment clause)
Stella Pharma: Matters omitted from the notice of convocation of the 2024 Annual General Meeting of Shareholders (electronic provision measures)
Stella Pharma: 2024 Annual General Meeting of Shareholders Convocation Notice
Stella Pharma: Notice regarding the formulation of the Mid-Term Management Plan 2027
Stella Pharma: Financial results briefing materials for the fiscal year ending March 2024
Stella Pharma: Independent Officer Notification Form
Stella Pharma: Notice regarding changes in representative directors and personnel affairs of officers
No Data